India Pesticides Ltd

AI
India Pesticides Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

India Pesticides Ltd

₹ 115 -0.20%
04 Nov - close price
indiapesticideslimited.com BSE: 543311 NSE: IPL
About

India Pesticides Limited is one of the globally operating agro-chemical manufactures in India, since 1984. The company is the sole Indian manufacturer and among the top five manufacturers globally for several Technicals, such as Folpet, Thiocarbamate Herbicide, and several other products [1]

Key Points

Leading Pesticides company[1]
India Pesticides is an R&D-driven chemical manufacturer of agrochemical technical, APIs, and formulation business.

Website BSE NSE
  • Market Cap ₹ 1,326 Cr.
  • Current Price ₹ 115
  • High / Low ₹ 198 / 109
  • Stock P/E 13.6
  • Book Value ₹ 91.3
  • Dividend Yield 0.65 %
  • ROCE 17.1 %
  • ROE 12.7 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of 10.2% over past five years.
  • Company has a low return on equity of 10.2% over last 3 years.
  • Dividend payout has been low at 10.5% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals

Part of BSE Commodities BSE 1000

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
202 151 127 220 229 172 208 275 290 226 266 253 226
175 118 123 192 195 145 176 230 241 188 224 217 195
Operating Profit 27 33 4 29 34 27 32 46 49 38 43 36 31
OPM % 13% 22% 3.1% 13% 15% 16% 15% 17% 17% 17% 16% 14% 14%
4 4 4 4 6 3 3 9 5 3 4 4 3
Interest 1 1 1 1 1 1 1 2 1 2 3 3 2
Depreciation 4 4 4 4 4 5 5 5 5 5 5 6 6
Profit before tax 27 33 2 27 34 24 29 48 48 34 39 31 26
Tax % 26% 26% 56% 27% 23% 29% 24% 26% 33% 33% 19% 27% 25%
20 24 1 20 26 17 22 35 32 23 32 23 19
EPS in Rs 1.72 2.12 0.09 1.74 2.30 1.51 1.94 3.07 2.78 2.01 2.76 2.00 1.68
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
223 248 341 480 649 716 885 681 829 1,057 971
163 193 275 386 466 502 687 594 708 881 823
Operating Profit 60 55 65 94 183 214 198 87 121 176 148
OPM % 27% 22% 19% 20% 28% 30% 22% 13% 15% 17% 15%
2 3 5 10 6 13 13 15 15 21 14
Interest 6 4 6 5 3 7 6 4 4 7 9
Depreciation 3 4 4 5 6 8 11 15 18 21 22
Profit before tax 53 50 61 93 180 212 193 84 114 169 131
Tax % 33% 35% 28% 24% 25% 25% 25% 27% 26% 28%
35 33 44 71 135 158 144 61 84 122 97
EPS in Rs 31.64 29.29 39.21 63.21 12.04 13.75 12.54 5.31 7.33 10.62 8.45
Dividend Payout % 2% 2% 1% 5% 3% 5% 6% 14% 10% 7%
Compounded Sales Growth
10 Years: %
5 Years: 10%
3 Years: 6%
TTM: 3%
Compounded Profit Growth
10 Years: %
5 Years: -2%
3 Years: -5%
TTM: -9%
Stock Price CAGR
10 Years: %
5 Years: -20%
3 Years: -27%
1 Year: -38%
Return on Equity
10 Years: 18%
5 Years: 15%
3 Years: 10%
Last Year: 13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 3 3 3 3 11 12 12 12 12 12 12
Reserves 107 141 184 254 378 627 763 816 892 1,006 1,040
43 46 61 28 30 15 6 20 56 77 53
42 51 69 81 97 131 135 148 183 211 245
Total Liabilities 195 240 317 366 517 784 915 996 1,142 1,306 1,349
61 69 70 99 124 163 237 267 313 369 374
CWIP 3 3 5 1 12 44 27 41 36 19 15
Investments 2 3 3 3 10 20 17 41 59 78 92
130 165 239 262 371 557 635 647 735 840 868
Total Assets 195 240 317 366 517 784 915 996 1,142 1,306 1,349

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
38 16 -3 75 83 77 46 120 2 68
-6 -13 -7 -31 -84 -133 -23 -125 -16 -62
-32 -2 9 -39 -4 71 -29 2 19 7
Net Cash Flow 0 1 -1 5 -5 14 -6 -3 5 13
Free Cash Flow 34 4 -11 44 41 -3 -27 61 -48 7
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 91% 57% 21% 104% 70% 61% 47% 162% 20% 62%

Ratios

Standalone / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 143 184 191 139 120 126 108 128 152 125
Inventory Days 56 75 56 88 163 175 201 204 189
Days Payable 108 116 89 92 110 74 90 99 90
Cash Conversion Cycle 143 132 150 106 116 179 209 240 257 224
Working Capital Days 102 110 128 119 120 159 164 184 180 163
ROCE % 32% 30% 37% 52% 41% 28% 11% 13% 17%

Insights

In beta
Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Export Revenue Share
%

Log in to view insights

Please log in to see hidden values.

Login
Top 10 Customer Revenue Concentration
%
Formulations Installed Capacity
MT
Technicals Installed Capacity
MT
Number of Exporting Countries
Count
Capacity Utilization
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

10 Recently
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
63.61% 63.61% 63.61% 63.61% 63.61% 63.62% 63.62% 63.65% 63.65% 63.65% 63.65% 63.65%
1.63% 2.40% 0.26% 0.32% 1.75% 1.84% 2.52% 2.78% 1.88% 1.87% 0.20% 0.09%
1.59% 0.04% 0.04% 0.05% 0.06% 0.00% 0.00% 0.02% 0.03% 0.02% 0.02% 0.02%
33.17% 33.95% 36.10% 36.01% 34.59% 34.55% 33.85% 33.54% 34.43% 34.46% 36.14% 36.24%
No. of Shareholders 98,75895,75899,8821,05,6001,07,4611,06,9741,00,62895,31495,45693,55194,07595,430

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls